EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance

Chiara La Guidara iD, Roberto Adamo iD, Claudia Sala iD, Francesca Micoli

International Journal of Molecular Sciences · 17.05.2024 · 25 (10) · 5487

DOI: 10.3390/ijms25105487 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.05.2024. Verfasst von Chiara La Guidara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Magnetic Resonance Center CERM, University of Florence, 50019 Florence, Italy. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Anti-Bacterial Agents. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) is one of the most critical threats to global public health in the 21st century, causing a large number of deaths every year in both high-income and low- and middle-income countries. Vaccines and monoclonal antibodies can be exploited to prevent and treat diseases caused by AMR pathogens, thereby reducing antibiotic use and decreasing selective pressure that favors the emergence of resistant strains. Here, differences in the mechanism of action and resistance of vaccines and monoclonal antibodies compared to antibiotics are discussed. The state of the art for vaccine technologies and monoclonal antibodies are reviewed, with a particular focus on approaches validated in clinical studies. By underscoring the scope and limitations of the different emerging technologies, this review points out the complementary of vaccines and monoclonal antibodies in fighting AMR. Gaps in antigen discovery for some pathogens, as well as challenges associated with the clinical development of these therapies against AMR pathogens, are highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalAnti-Bacterial AgentsHumansAnimalsDrug Resistance, BacterialBacterial VaccinesBacterial Infections

Stichwörter der Autor:innen

antibioticsantimicrobial resistanceinnovative technologiesmode of actionmonoclonal antibodiesvaccines

Substanzen

Antibodies, MonoclonalAnti-Bacterial AgentsBacterial Vaccines

Autor:innen und Institutionen

  • Magnetic Resonance Center CERM, University of Florence, 50019 Florence, Italy.
  • Department of Chemistry "Ugo Schiff", University of Florence, 50019 Florence, Italy.
  • GSK, 53100 Siena, Italy.
  • Monoclonal Antibody Discovery Laboratory, Fondazione Toscana Life Sciences, 53100 Siena, Italy.
  • GSK Vaccines Institute for Global Health S.R.L. (GVGH), 53100 Siena, Italy.

ORCID-Profile: Chiara La Guidara, Roberto Adamo, Claudia Sala

Zitieren

APA

La Guidara, C., Adamo, R., Sala, C., & Micoli, F. (2024). Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance. International Journal of Molecular Sciences, 25(10), 5487. https://doi.org/10.3390/ijms25105487

Vancouver

La Guidara C, Adamo R, Sala C, Micoli F. Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance. International Journal of Molecular Sciences. 2024;25(10):5487. doi:10.3390/ijms25105487

BibTeX
@article{LaGuidara2024,
  author = {La Guidara, Chiara and Adamo, Roberto and Sala, Claudia and Micoli, Francesca},
  title = {Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {10},
  pages = {5487},
  doi = {10.3390/ijms25105487}
}
Kostenlos starten →